Entertainment

PropNex Unveils a Bold New Brand Identity and Appoints Key Strategic Leaders; Launches New Property Investment Book

SINGAPORE,March 10,2025-- Singapore\'s largest real estate agency,PropNex Limited,has unveiled a refreshed brand logo after 25 years,signaling a new phase of growth and strategic direction. This mark

03-11

Phoenix Aviation Capital, AIP Capital and LuminArx Announce Acquisition of Three Airbus A330-300 Aircraft

Acquired aircraft are currently on lease to China Airlines and EVA Air DUBLIN and STAMFORD,Conn. and NEW YORK,March 10,2025-- Phoenix Aviation Capital ("Phoenix"),a full-service aircraft le

03-11

STRADVISION Surpasses 3 Million Units in Cumulative Production, Achieving a Record-Breaking Year in 2024

SEOUL,South Korea,March 11,2025--STRADVISION,a global leader in AI-powered vision perception technology,proudly announces a new industry milestone,surpassing 3 million units in cumulative commercial

03-11

Impact X returns as marquee event of Climate Action Week Sydney

SYDNEY,March 11,2025-- Australia\'s largest climate and nature summitImpact X returns for its fourth year as a marquee event of Climate Action Week Sydney,with 500+ attendees and 50+ speakers from acr

03-11

Magcubic Disrupts the Smart Projector Market with Affordable Products for Everyone

BEIJING,March 11,2025-- Smart projectors can transform virtually any wall into a smart display,but their expensive price tags make them unrealistic for most buyers. Magcubic set out to revolutionize t

03-11

Proteus powered Hindalco digital manufacturing platform wins this year's national manufacturing leadership award

SINGAPORE,March 8,2025-- #dltledgers collaboration with its client,Hindalco Industries Limited (Hindalco),an Aditya Birla Group company is one of mutual success. A case study where its client,Hindalco

03-11 dltledgers

U.S. FDA approves Celltrion's OMLYCLO® (omalizumab-igec) as the first and only biosimilar with interchangeability designation referencing XOLAIR®

OMLYCLO® (omalizumab-igec) is the first and only omalizumab biosimilar approved by the FDA Regulatory approval for interchangeability was supported by positive phase III data demonstrating compar

03-11 Celltrion

Next-Gen ProAV: Hikvision rolls out an evolving audio-visual ecosystem with digital innovations at ISLE 2025

HANGZHOU,China,March 10,2025-- As an innovative industry pioneer,Hikvision has elevated ProAV by showcasing immersive experiences at ISLE 2025. This landmark demonstration reflects Hikvision\'s ongoin

03-11 Hikvision Digital Technology

Webull Debuts Enhanced Brokerage Services with Webull Premium

A subscription-based product designed to elevate the retail investing experience NEW YORK,March 10,2025--Webull,a leading online investment platform,today announced it will be launching Webull Premiu

03-11 Webull Financial LLC

Yonsei University to Host GEEF 2025, Exploring Innovative Solutions for the SDGs

GEEF 2025 will take place on March 13–14,bringing together 83 speakers from 14 countries to discuss solutions for bridging societal divides.

03-11 GEEF 2025